English
This article is from African Journal of Infectious Diseases , volume 5 . Abstract Praziquantel (PZQ) is efficacious against Schistosoma mansoni. This was prospective cohort study. This study was carried out at Kigungu fishing village, Entebbe, Uganda. The goal of the study was to establish cost effective regiment for mass drug administration (MDA) of Praziquentel in the morbidity reduction of S.mansoni infection. In January 2004, nine hundred and forty five (945) participants were registered in this study. Our analysis was based on examining microscopically three slides prepared from each of 945 stool specimens delivered by each of the participant using modified Kato/Katz method. These included male and female, children and adults living in Kigungu fishing village in Entebbe Uganda. In total 901, cohorts were re-examined for infections clearance six months later in July 2004 and 18 months later in June 2005, 625 cohorts were again re-evaluated for S.mansoni infections after the baseline study. At baseline, (448) of 945 (47.5%) cohorts were S. mansoni positive. All these participants were treatment with a single oral dose of praziquantel at 40mg/kg. At the same time, 495 (52.5%) wer
Sign in with your free account to read, download EPUBs or listen.
Ebook · Evidence of Long Term Benefit of Morbidity Reduction Due to Praziquantel Treatment Against Schistosoma Mansoni in Kigungu Fishing Village in Entebbe, Uganda. · Odongo-Aginya, Emmanuel I, Kironde, FK, Lyazi, MI, Sempewo, Harman, Correa Oliveira, Rodrigo · Internet Archive